A post-COVID 'transition period for the company as it returns to 'business as usual'

August 23, 2024 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

Leading pathology company Sonic Healthcare has released its full-year results for 2024, confirming that the world has well and truly moved on from the pandemic. …

Subscribe now to continue reading.

Latest Video

Full credit for the honesty, but this is Pharmac and not even in disguise
September 10, 2024 - Latest News
This one proposal could deliver the single biggest destruction of therapeutic value
September 11, 2024 - Latest News
This report prioritises therapies that deliver government savings over those that benefit patients
September 11, 2024 - Latest News
In 236 pages, this one section captures the primary barrier to real reform
September 13, 2024 - Latest News
A response that risks upfront acceptance of changes to deliver billions in new savings
September 11, 2024 - Latest News

A post-COVID 'transition period for the company as it returns to 'business as usual'

This is a preview of subscriber content

Latest Video

Most Read

Full credit for the honesty, but this is Pharmac and not even in disguise

This one proposal could deliver the single biggest destruction of therapeutic value

This report prioritises therapies that deliver government savings over those that benefit patients

In 236 pages, this one section captures the primary barrier to real reform

A response that risks upfront acceptance of changes to deliver billions in new savings

New Stories

In 236 pages, this one section captures the primary barrier to real reform

It is never too late for a considered response - caution

The 'Week in Review' Podcast - 13 September

'HTA review will achieve savings, but it won’t achieve better access for all'

PharmaPrograms announces extension of long-standing partnership with NostraData

Telix’s Phase 3 ZIRCON trial for kidney cancer imaging published in The Lancet Oncology

Brandon BioCatalyst’s CUREator Incubator boosts preclinical and health security innovations with new funding

Sign In

A post-COVID 'transition period for the company as it returns to 'business as usual'

This is a preview of subscriber content

Latest Video

Most Read

Full credit for the honesty, but this is Pharmac and not even in disguise

This one proposal could deliver the single biggest destruction of therapeutic value

This report prioritises therapies that deliver government savings over those that benefit patients

In 236 pages, this one section captures the primary barrier to real reform

A response that risks upfront acceptance of changes to deliver billions in new savings

Follow Us

New Stories

In 236 pages, this one section captures the primary barrier to real reform

It is never too late for a considered response - caution

The 'Week in Review' Podcast - 13 September

'HTA review will achieve savings, but it won’t achieve better access for all'

PharmaPrograms announces extension of long-standing partnership with NostraData

Telix’s Phase 3 ZIRCON trial for kidney cancer imaging published in The Lancet Oncology

Brandon BioCatalyst’s CUREator Incubator boosts preclinical and health security innovations with new funding